Work

18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation

Year: 2024

Type: article

Abstract: Flourine 18 fluorothymidine PET has the potential to be a valuable tool in the identification of clinical and subclinical gastrointestinal graft versus host disease (GI-GVHD) and, if validated, could serve as an imaging biomarker for GI-GVHD.

Source: Radiology Imaging Cancer

DOI: 10.1148/rycan.240096

Authors: Jennifer Holter-Chakrabarty, Lacey McNally, John Levine, James Ferrara, Sara K. Vesely, Christopher G. Kanakry, Tabitha Garwe, Zheng Han, Manu Pandey, Joshua Glover, Yuejin Wen, Ron Gress, Kirsten M. Williams

Institutions: National Cancer Institute, Tisch Cancer Institute, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Oklahoma Tobacco Settlement Endowment Trust, U.S. Department of Health and Human Services, University of Oklahoma, Tobacco Settlement Endowment Trust, National Institutes of Health, Stephenson Cancer Center, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G3503792436, G386607036, Imaging and Blood Biomarkers to Predict Graft Failure after HSCT, G4388466716, G4585269469, G501766673, G5614872079, G5737582129, Non-invasive assessment of graft vs host disease using optoacoustic imaging, G5888954722, G9000235584, Development of contrast agents to facilitate image-guided surgery, Stephenson Cancer Center - Cancer Center Support Grant

OpenAlex ID: W4405368259

FWCI: 0.534

Cites: 42

Cited by: 2

Related to: 10